2006 Heart-Brain summit proceedings

Inflammation: Implications for understanding the heart-brain connection

Mehdi H. Shishehbor, DO

Department of Cardiovascular Medicine
Cleveland Clinic
Cleveland, OH

Carlos Alves, MD

Department of Cardiovascular Medicine
Cleveland Clinic
Cleveland, OH

 

Vivek Rajagopal, MD

Department of Cardiovascular Medicine
Cleveland Clinic
Cleveland, OH

ARTICLE INTRODUCTION

Autonomic dysfunction is a strong correlate of morbidity and mortality in cardiovascular disease. While increased sympathetic stimulation drives many adverse events in coronary artery disease and heart failure, beta-adrenergic blockade is associated with improved outcomes. Similarly, diminished parasympathetic tone is also associated with adverse outcomes in cardiovascular disease, suggesting a key role for this limb of the autonomic system in maintenance of cardiac homeostasis.

The mechanism of parasympathetic protection, however, is not clearly understood. Although an antiarrhythmic mechanism appears intuitive, such a mechanism has not been corroborated by animal studies. Recently, Tracey and colleagues provided new insight by demonstrating that parasympathetic stimulation in mice and in human macrophages results in a decreased release of mediators of systemic inflammation. Given the importance of inflammation in atherosclerosis and adverse remodeling in congestive heart failure, it is possible that parasympathetic tone assuages atherogenesis and deleterious cardiac remodeling by directly inhibiting inflammation.

CITATIONS

  1. Schwartz PJ, La Rovere MT, Vanoli E.
    Autonomic nervous system and sudden cardiac death. Experimental basis and clinical observations for post-myocardial infarction risk stratification. Circulation 1992; 85(Suppl 1):I77–I91.
    http://www.ncbi.nlm.nih.gov/pubmed/1728509

  2. Gheorghiade M, Goldstein S.
    Beta-blockers in the post-myocardial infarction patient. Circulation 2002; 106:394–398.
    http://www.ncbi.nlm.nih.gov/pubmed/12135934
  3. Jessup M, Brozena S.
    Heart failure. N Engl J Med 2003; 348:2007–2018.
    http://www.ncbi.nlm.nih.gov/pubmed/12748317
  4. Hull SS Jr, Vanoli E, Adamson PB, De Ferrari GM, Foreman RD, Schwartz PJ.
    Do increases in markers of vagal activity imply protection from sudden death? The case of scopolamine. Circulation 1995 ;91:2516–2519.
    http://www.ncbi.nlm.nih.gov/pubmed/7743612
  5. Borovikova LV, Ivanova S, Zhang M, et al.
    Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin. Nature 2000; 405:458–462.
    http://www.ncbi.nlm.nih.gov/pubmed/10839541
  6. Wang H, Yu M, Ochani M, et al.
    Nicotinic acetylcholine receptor _7 subunit is an essential regulator of inflammation. Nature 2003; 421:384–388.
    http://www.ncbi.nlm.nih.gov/pubmed/12508119
  7. Diwan A, Tran T, Misra A, Mann DL.
    Inflammatory mediators and the failing heart: a translational approach. Curr Mol Med 2003; 3:161–182.
    http://www.ncbi.nlm.nih.gov/pubmed/12630562
  8. Fan J, Watanabe T.
    Inflammatory reactions in the pathogenesis of atherosclerosis. J Atheroscler Thromb 2003; 10:63–71.
    http://www.ncbi.nlm.nih.gov/pubmed/12740479
  9. Shishehbor MH, Bhatt DL.
    Inflammation and atherosclerosis. Curr Atheroscler Rep 2004; 6:131–139.
    http://www.ncbi.nlm.nih.gov/pubmed/15023298
  10. La Rovere MT, Bigger JT Jr, Marcus FI, Mortara A, Schwartz PJ.
    Baroreflex sensitivity and heart-rate variability in prediction of total cardiac mortality after myocardial infarction. ATRAMI (Autonomic Tone and Reflexes After Myocardial Infarction) Investigators. Lancet 1998; 351:478–484.
    http://www.ncbi.nlm.nih.gov/pubmed/9482439
  11. Nolan J, Batin PD, Andrews R, et al.
    Prospective study of heart rate variability and mortality in chronic heart failure: results of the United Kingdom Heart Failure Evaluation and Assessment of Risk Trial (UK-HEART). Circulation 1998; 98:1510–1516.
    http://www.ncbi.nlm.nih.gov/pubmed/9769304
  12. Cole CR, Blackstone EH, Pashkow FJ, Snader CE, Lauer MS.
    Heart-rate recovery immediately after exercise as a predictor of mortality. N Engl J Med 1999; 341:1351–1357.
    http://www.ncbi.nlm.nih.gov/pubmed/10536127
  13. Cole CR, Foody JM, Blackstone EH, Lauer MS.
    Heart rate recovery after submaximal exercise testing as a predictor of mortality in a cardiovascularly healthy cohort. Ann Intern Med 2000; 132:552–555.
    http://www.ncbi.nlm.nih.gov/pubmed/10744592
  14. Shishehbor MH, Baker DW, Blackstone EH, Lauer MS.
    Association of educational status with heart rate recovery: a popula- INFLAMMATION
    S40 CLEVELAND CLINIC JOURNAL OF MEDICINE VOLUME 74 • SUPPLEMENT 1 FEBRUARY 2007 tion-based propensity analysis. Am J Med 2002; 113:643–649.
    http://www.ncbi.nlm.nih.gov/pubmed/12505114
  15. Seshadri N, Gildea TR, McCarthy K, Pothier C, Kavuru MS, Lauer MS.
    Association of an abnormal exercise heart rate recovery with pulmonary function abnormalities. Chest 2004; 125:1286–1291.
    http://www.ncbi.nlm.nih.gov/pubmed/15078736
  16. Chen MS, Blackstone EH, Pothier CE, Lauer MS.
    Heart rate recovery and impact of myocardial revascularization on long-term mortality. Circulation 2004; 110:2851–2857.
    http://www.ncbi.nlm.nih.gov/pubmed/15505081
  17. Cheng YJ, Lauer MS, Earnest CP, et al.
    Heart rate recovery following maximal exercise testing as a predictor of cardiovascular disease and all-cause mortality in men with diabetes. Diabetes Care 2003; 26:2052–2057.
    http://www.ncbi.nlm.nih.gov/pubmed/12832312
  18. Jouven X, Empana JP, Schwartz PJ, Desnos M, Courbon D, Ducimetiere P.
    Heart-rate profile during exercise as a predictor of sudden death. N Engl J Med 2005; 352:1951–1958.
    http://www.ncbi.nlm.nih.gov/pubmed/15888695
  19. Aronson D, Mittleman MA, Burger AJ.
    Interleukin-6 levels are inversely correlated with heart rate variability in patients with decompensated heart failure. J Cardiovasc Electrophysiol 2001; 12:294–300.
    http://www.ncbi.nlm.nih.gov/pubmed/11291801
  20. Lanza GA, Sgueglia GA, Cianflone D, et al.
    Relation of heart rate variability to serum levels of C-reactive protein in patients with unstable angina pectoris. Am J Cardiol 2006; 97:1702–1706.
    http://www.ncbi.nlm.nih.gov/pubmed/16765117
  21. Tracey KJ.
    The inflammatory reflex. Nature 2002; 420:853–859.
    http://www.ncbi.nlm.nih.gov/pubmed/12490958
  22. Pavlov VA, Tracey KJ.
    The cholinergic anti-inflammatory pathway. Brain Behav Immun 2005; 19:493–499.
    http://www.ncbi.nlm.nih.gov/pubmed/15922555
  23. Metz CN, Tracey KJ.
    It takes nerve to dampen inflammation. Nat Immunol 2005; 6:756–757.
    http://www.ncbi.nlm.nih.gov/pubmed/16034431
  24. de Jonge WJ, van der Zanden EP, The FO, et al.
    Stimulation of the vagus nerve attenuates macrophage activation by activating the Jak2-STAT3 signaling pathway. Nat Immunol 2005; 6:844–851.
    http://www.ncbi.nlm.nih.gov/pubmed/16025117
  25. Liu H, Yao YM, Dong YQ, Yu Y, Sheng ZY.
    The role of Janus kinase-signal transducer and transcription activator pathway in the regulation of synthesis and release of lipopolysaccharide-induced high mobility group box-1 protein. Zhonghua Shao Shang Za Zhi 2005; 21:414–417.
    http://www.ncbi.nlm.nih.gov/pubmed/16480616
  26. Muthian G, Bright JJ.
    Quercetin, a flavonoid phytoestrogen, ameliorates experimental allergic encephalomyelitis by blocking IL-12 signaling through JAK-STAT pathway in T lymphocyte. J Clin Immunol 2004; 24:542–552.
    http://www.ncbi.nlm.nih.gov/pubmed/15359113
  27. Saeed RW, Varma S, Peng-Nemeroff T, et al.
    Cholinergic stimulation blocks endothelial cell activation and leukocyte recruitment during inflammation. J Exp Med 2005; 201:1113–1123.
    http://www.ncbi.nlm.nih.gov/pubmed/15809354